CJC-1295 without DAC 5mg + Ipamorelin 5mg

CJC-1295 without DAC 5mg + Ipamorelin 5mg

$60.00

Quick Payment

100% New

Fast Delivery

Description

CJC-1295 (Without DAC) 5mg + Ipamorelin 5mg (Growth Hormone Secretagogue Blend)

Description

CJC-1295 (without DAC) and Ipamorelin are synthetic peptides studied together for their combined effects on endogenous growth hormone release and recovery-related pathways.
CJC-1295 without DAC functions as a Growth Hormone-Releasing Hormone (GHRH) analogue, while Ipamorelin acts as a selective ghrelin receptor agonist, making this combination a commonly researched synergistic growth hormone secretagogue blend.


Key benefits (research findings)

Studied for synergistic stimulation of natural growth hormone release.
May support recovery, tissue repair, and muscle-recovery pathways in experimental models.
Evaluated for potential effects on sleep quality, body composition, and metabolic regulation.
Ipamorelin is researched for selective GH release with minimal impact on cortisol and prolactin compared to some older secretagogues.


Who it’s for

Researchers investigating growth hormone dynamics, recovery pathways, and metabolic-support mechanisms.
Intended strictly for laboratory and investigational use; not for individual or unsupervised administration.


Suggested use

Administered in research environments according to established protocols; dosing schedules and frequency vary by study design.
This combination is often evaluated in multi-dose protocols intended to mimic physiologic growth hormone pulsatility—follow all laboratory guidelines and protocol requirements.


Safety and storage

Research observations may include injection-site irritation, flushing, water retention, headache, or transient hormonal fluctuations depending on study conditions.
Proper sterile handling and laboratory safety procedures should always be followed.
Store according to manufacturer or protocol guidelines (typically refrigerated and protected from light); maintain sterility and peptide integrity.


Quick facts

Mechanism: combined GHRH receptor activation and ghrelin receptor agonism to stimulate endogenous growth hormone release.
Status: investigational peptide blend; not approved for therapeutic use.
Studied for: recovery, body composition, sleep-related pathways, and growth hormone optimization research.


Research Use Only Disclaimer

Products sold by SoCo Peptides are intended strictly for laboratory research purposes only.

These compounds are not intended for human consumption, veterinary use, household use, cosmetic use, or therapeutic application. They are not drugs, foods, or dietary supplements and have not been evaluated or approved by the FDA.

By purchasing from this website, the customer represents that they are a qualified researcher or laboratory professional and understand the risks associated with handling research materials.

All products must be handled by trained professionals in appropriate research facilities and in accordance with all applicable laws and regulations.

SoCo Peptides makes no guarantees or claims regarding safety, effectiveness, or medical benefit.

Additional information

Size

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 without DAC 5mg + Ipamorelin 5mg”

Your email address will not be published. Required fields are marked *

Important Notice

Account Required to View Products

Industry Notice

Due to recent industry changes, customers are now required to create an account and log in to view our product catalog.

21+

By creating an account you confirm you are at least 21 years of age and acknowledge all products are for research purposes only — not for human consumption.